<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jairath NK</submitter><funding>National Psoriasis Foundation</funding><funding>Foundation for the National Institutes of Health</funding><funding>Dermatology Foundation</funding><pagination>e0277655</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9668185</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(11)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Large cell transformation (LCT) of Sezary Syndrome (SS) is a rare phenomenon. To date, there are no rigorous studies identifying risk factors for its development.&lt;h4>Objectives&lt;/h4>Here, we seek to characterize the clinicopathologic risk factors that predispose patients with SS to develop LCT.&lt;h4>Methods&lt;/h4>We retrospectively evaluated all SS patient records available in the Michigan Medicine Cancer Registry from 2010-2021. Clinical and pathologic variables were compared between groups. The Kaplan-Meier method and log-rank test were used to assess overall survival.&lt;h4>Results&lt;/h4>Of 28 SS patients identified, eight patients experienced LCT, and 20 did not (NLCT). Peak lactate dehydrogenase (LDH) before LCT (p = 0.0012), maximum total body surface area (TBSA) involvement</pubmed_abstract><journal>PloS one</journal><pubmed_title>Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis.</pubmed_title><pmcid>PMC9668185</pmcid><funding_grant_id>K01-AR072129</funding_grant_id><pubmed_authors>Bardhi R</pubmed_authors><pubmed_authors>Tejasvi T</pubmed_authors><pubmed_authors>Hristov AC</pubmed_authors><pubmed_authors>Runge JS</pubmed_authors><pubmed_authors>Jairath R</pubmed_authors><pubmed_authors>Patrick M</pubmed_authors><pubmed_authors>Jairath NK</pubmed_authors><pubmed_authors>Tsoi LC</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wilcox RA</pubmed_authors><pubmed_authors>Bledea R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis.</name><description>&lt;h4>Background&lt;/h4>Large cell transformation (LCT) of Sezary Syndrome (SS) is a rare phenomenon. To date, there are no rigorous studies identifying risk factors for its development.&lt;h4>Objectives&lt;/h4>Here, we seek to characterize the clinicopathologic risk factors that predispose patients with SS to develop LCT.&lt;h4>Methods&lt;/h4>We retrospectively evaluated all SS patient records available in the Michigan Medicine Cancer Registry from 2010-2021. Clinical and pathologic variables were compared between groups. The Kaplan-Meier method and log-rank test were used to assess overall survival.&lt;h4>Results&lt;/h4>Of 28 SS patients identified, eight patients experienced LCT, and 20 did not (NLCT). Peak lactate dehydrogenase (LDH) before LCT (p = 0.0012), maximum total body surface area (TBSA) involvement</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-06-01T01:36:09.434Z</modification><creation>2025-06-01T01:36:09.434Z</creation></dates><accession>S-EPMC9668185</accession><cross_references><pubmed>36383618</pubmed><doi>10.1371/journal.pone.0277655</doi></cross_references></HashMap>